649P Phase I study of SHR-A2102, a nectin-4 targeted ADC, in patients with advanced solid tumors

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Annals of Oncology

Topics

Medicine

Cancer Oncology

Immunology

Internal Medicine

Nuclear Medicine

Show all topics

DOI

10.1016/j.annonc.2024.08.715